Covered recipient · General Payments record
BRYAN E CAUDLE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$834.85
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $620.95 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $259.40 | 13 |
| Novo Nordisk AS | $131.77 | 6 |
| DEXCOM, INC. | $76.36 | 3 |
| Exact Sciences Corporation | $45.48 | 3 |
| Amgen Inc. | $35.68 | 2 |
| Abbott Laboratories | $24.36 | 1 |
| Lilly USA, LLC | $17.73 | 1 |
| Acerta Pharma LLC | $15.98 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.36 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125377717 | CMS |
| ABBVIE INC. | $21.31 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429698 | CMS |
| ABBVIE INC. | $6.71 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429700 | CMS |
| ABBVIE INC. | $29.97 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429702 | CMS |
| ABBVIE INC. | $16.65 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429704 | CMS |
| ABBVIE INC. | $34.00 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429706 | CMS |
| ABBVIE INC. | $19.37 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429708 | CMS |
| ABBVIE INC. | $24.72 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429710 | CMS |
| ABBVIE INC. | $0.13 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429712 | CMS |
| ABBVIE INC. | $11.80 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429714 | CMS |
| ABBVIE INC. | $35.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429716 | CMS |
| ABBVIE INC. | $28.80 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429718 | CMS |
| ABBVIE INC. | $15.26 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429720 | CMS |
| ABBVIE INC. | $15.68 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429722 | CMS |
| Amgen Inc. | $20.08 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117220316 | CMS |
| Amgen Inc. | $15.60 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111544433 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.98 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104724701 | CMS |
| Dexcom, Inc. | $36.93 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289355 | CMS |
| Dexcom, Inc. | $19.07 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289359 | CMS |
| Dexcom, Inc. | $20.36 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289363 | CMS |
| Exact Sciences Corporation | $13.99 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114447113 | CMS |
| Exact Sciences Corporation | $14.58 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114447117 | CMS |
| Exact Sciences Corporation | $16.91 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114447121 | CMS |
| Lilly USA, LLC | $17.73 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136085224 | CMS |
| Novo Nordisk Inc | $22.41 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096782708 | CMS |
| Novo Nordisk Inc | $20.06 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096597450 | CMS |
| Novo Nordisk Inc | $23.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096746130 | CMS |
| Novo Nordisk Inc | $23.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097662828 | CMS |
| Novo Nordisk Inc | $23.00 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097618708 | CMS |
| Novo Nordisk Inc | $20.30 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096893609 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.19 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144589444 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.